Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 32, 1997 - Issue 10
Submit an article Journal homepage
259
Views
120
CrossRef citations to date
0
Altmetric
Original Article

Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93

B. Moum Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
A. Ekbom Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
M. H. Vatn Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
E. Aadland Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
J. Sauar Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
I. Lygren Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
T. Schulz Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
,
N. Stray Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
&
O. Fausa Cancer Epidemiology Unit, University Hospital, Uppsala, Sweden; Dept. of Internal Medicine, østfold Central Hospital, Fredrikstad; Dept. of Internal Medicine, Telemark Central Hospital, Skien; Dept. of Internal Medicine, Aust-Agder Central Hospital, Arendal; Dept. of Medicine A, The National Hospital, Oslo, Norway; Dept. of Internal Medicine, Aker University Hospital, Oslo, Norway; Dept. of Internal Medicine, Ullevål University Hospital, Oslo, Norway; Dept. of Internal Medicine, Norwegian Lutheran Hospital, Oslo, Norway
 show all
Pages 1005-1012 | Received 13 Mar 1997, Accepted 21 May 1997, Published online: 08 Jul 2009

Citations (120)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Gert Huppertz-Hauss, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Randi Opheim, Magne Henriksen, Ole Høie, Øistein Hovde, Iril Kempski-Monstad, Inger Camilla Solberg, Jørgen Jahnsen, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Scandinavian Journal of Gastroenterology 52:3, pages 351-358.
Read now
Kieran Keohane, Mónica Rosa, Ivan S. Coulter & Brendan T. Griffin. (2016) Enhanced colonic delivery of ciclosporin A self-emulsifying drug delivery system encapsulated in coated minispheres. Drug Development and Industrial Pharmacy 42:2, pages 245-253.
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
. (2010) Abstract book for 41st Nordic Gastroenterology Congress. Scandinavian Journal of Gastroenterology 45:sup247, pages 1-65.
Read now
Inger Camilla Solberg, Idar Lygren, Jørgen Jahnsen, Erling Aadland, Ole Høie, Milada Cvancarova, Tomm Bernklev, Magne Henriksen, Jostein Sauar, Morten H. Vatn, Bjørn Moum & And the IBSEN Study Group. (2009) Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology 44:4, pages 431-440.
Read now
Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Erling Aadland, Tom Schulz, Morten H. Vatn, Bjørn Moum & THE IBSEN STUDY GROUP. (2007) Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study). Scandinavian Journal of Gastroenterology 42:5, pages 602-610.
Read now

Articles from other publishers (113)

Kohei Ogasawara, Hiroto Hiraga, Yoshihiro Sasaki, Noriko Hiraga, Naoki Higuchi, Keisuke Hasui, Shinji Ota, Takato Maeda, Yasuhisa Murai, Tetsuya Tatsuta, Hidezumi Kikuchi, Daisuke Chinda, Tatsuya Mikami, Masashi Matsuzaka, Hirotake Sakuraba & Shinsaku Fukuda. (2023) A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn’s Disease Using a Brute Force Method. Diagnostics 13:23, pages 3587.
Crossref
Wenhao Wang, Shengyuan Jia, Guohou Miao, Zhenmin Sun, Feng Yu, Zhixing Gao & Yuli Li. (2023) Bioactive glass in the treatment of ulcerative colitis to regulate the TLR4 / MyD88 / NF-κB pathway. Biomaterials Advances 152, pages 213520.
Crossref
Yıldız KIRAÇ, Bektaş YALÇIN & Müge USTAOĞLU. (2023) The Relationship between Smoking Status, Carbon Monoxide Levels and Quality of Life, Disease Characteristics in Inflammatory Bowel Diseasesİnflamatuar Bağırsak Hastalıklarında Sigara İçme Durumu, Karbon Monoksit Düzeyleri ile Yaşam Kalitesi ve Hastalık Özellikleri Arasındaki İlişki. Konuralp Tıp Dergisi 15:1, pages 69-77.
Crossref
Noa Krugliak Cleveland, Joana Torres & David T. Rubin. (2022) What Does Disease Progression Look Like in Ulcerative Colitis, and How Might It Be Prevented?. Gastroenterology 162:5, pages 1396-1408.
Crossref
Cristina Rodríguez, Alfonso Elosua, Carlos Prieto, Ernesto Pérez, Rebeca Irisarri, Ana Campillo, Saioa Rubio, Óscar Nantes, Ramón Angós & José Manuel Zozaya. (2022) Tasas de colectomía en colitis ulcerosa 15 años después del diagnóstico. Datos de la cohorte Navarra 2001-2003. Gastroenterología y Hepatología 45:1, pages 1-8.
Crossref
Cristina Rodríguez, Alfonso Elosua, Carlos Prieto, Ernesto Pérez, Rebeca Irisarri, Ana Campillo, Saioa Rubio, Óscar Nantes, Ramón Angós & José Manuel Zozaya. (2022) Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort. Gastroenterología y Hepatología (English Edition) 45:1, pages 1-8.
Crossref
Iril Lovise Monstad, Inger Camilla Solberg, Milada Cvancarova, Oistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Eva Gunther, Bjørn Allan Moum, Njaal Stray, Morten Vatn, Ole Hoie & Jørgen Jahnsen. (2021) Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study. Journal of Crohn's and Colitis 15:6, pages 969-979.
Crossref
Baldeep Singh Pabla & David Allen Schwartz. (2020) Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterology Clinics of North America 49:4, pages 671-688.
Crossref
Jae Myung Cha, Sang Hyoung Park, Kyoung Hoon Rhee, Sung Noh Hong, Young-Ho Kim, Seung In Seo, Kyung Ho Kim, Seung Kyu Jeong, Ji Hyun Lee, Sun Yong Park, Hyunju Park, Joo Sung Kim, Jong Pil Im, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O Suh, Young Kyun Kim, Byong Duk Ye & Suk-Kyun Yang. (2020) Long-term prognosis of ulcerative colitis and its temporal changes between 1986 and 2015 in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea. Gut 69:8, pages 1432-1440.
Crossref
Mireia Lopez-Siles, Xavier Aldeguer, Miriam Sabat-Mir, Mariona Serra-Pagès, Sylvia H Duncan, Harry J Flint, L Jesús Garcia-Gil & Margarita Martinez-Medina. (2020) Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification. World Journal of Gastrointestinal Pathophysiology 11:3, pages 64-77.
Crossref
Pasquale Klepp, Stephan Brackmann, Milada Cvancarova, Marte Lie Hoivik, Øistein Hovde, Magne Henriksen, Gert Huppertz-Hauss, Tomm Bernklev, Ole Hoie, Iril Kempski-Monstad, Inger Camilla Solberg, Njaal Stray, Jorgen Jahnsen, Morten H Vatn & Bjorn Moum. (2020) Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study. BMJ Open Gastroenterology 7:1, pages e000361.
Crossref
Satoko Ohfuji. 2019. Epidemiological Studies of Specified Rare and Intractable Disease. Epidemiological Studies of Specified Rare and Intractable Disease 117 131 .
Nadia Pallotta, Giuseppina Vincoli, Patrizio Pezzotti, Maurizio Giovannone, Alessandro Gigliozzi, Danilo Badiali, Piero Vernia & Enrico Stefano Corazziari. (2018) A risk score system to timely manage treatment in Crohn’s disease: a cohort study. BMC Gastroenterology 18:1.
Crossref
Eun Suk Jung, Britt-Sabina Petersen, Gabriele Mayr, Jae Hee Cheon, Yunkoo Kang, Seok Joo Lee, Xiumei Che, Won Ho Kim, Seung Kim, Stefan Schreiber, Andre Franke & Hong Koh. (2018) Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 30:12, pages 1491-1496.
Crossref
Shailja C. Shah, Hamed Khalili, Corinne Gower-Rousseau, Ola Olen, Eric I. Benchimol, Elsebeth Lynge, Kári R. Nielsen, Paul Brassard, Maria Vutcovici, Alain Bitton, Charles N. Bernstein, Desmond Leddin, Hala Tamim, Tryggvi Stefansson, Edward V. LoftusJr.Jr., Bjørn Moum, Whitney Tang, Siew C. Ng, Richard Gearry, Brankica Sincic, Sally Bell, Bruce E. Sands, Peter L. Lakatos, Zsuzsanna Végh, Claudia Ott, Gilaad G. Kaplan, Johan Burisch & Jean-Frederic Colombel. (2018) Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology 155:4, pages 1079-1089.e3.
Crossref
Levente Parragi, N Fournier, Jonas Zeitz, Michael Scharl, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, A M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann, Claudia Anderegg, Peter Bauerfeind, Christoph Beglinger, Stefan Begré, Dominique Belli, JoséM Bengoa, Luc Biedermann, Beat Bigler, Janek Binek, Mirjam Blattmann, Stephan Boehm, Jan Borovicka, Christian P Braegger, Nora Brunner, Patrick Bühr, Bernard Burnand, Emanuel Burri, Sophie Buyse, Matthias Cremer, Dominique H Criblez, Philippe de Saussure, Lukas Degen, Joakim Delarive, Christopher Doerig, Barbara Dora, Gian Dorta, Mara Egger, Tobias Ehmann, Ali El-Wafa, Matthias Engelmann, Jessica Ezri, Christian Felley, Markus Fliegner, Nicolas Fournier, Montserrat Fraga, Pascal Frei, Remus Frei, Michael Fried, Florian Froehlich, Christian Funk, Raoul Ivano Furlano, Suzanne Gallot-Lavallée, Martin Geyer, Marc Girardin, Delphine Golay, Tanja Grandinetti, Beat Gysi, Horst Haack, Johannes Haarer, Beat Helbling, Peter Hengstler, Denise Herzog, Cyrill Hess, Klaas Heyland, Thomas Hinterleitner, Philippe Hiroz, Claudia Hirschi, Petr Hruz, Rika Iwata, Res Jost, Pascal Juillerat, Vera Kessler Brondolo, Christina Knellwolf, Christoph Knoblauch, Henrik Köhler, Rebekka Koller, Claudia Krieger-Grübel, Gerd Kullak-Ublick, Patrizia Künzler, Markus Landolt, Rupprecht Lange, Frank Serge Lehmann, Andrew Macpherson, Philippe Maerten, Michel H Maillard, Christine Manser, Michael Manz, Urs Marbet, George Marx, Christoph Matter, Valérie McLin, Rémy Meier, Martina Mendanova, Christa Meyenberger, Pierre Michetti, Benjamin Misselwitz, Darius Moradpour, Bernhard Morell, Patrick Mosler, Christian Mottet, Christoph Müller, Pascal Müller, Beat Müllhaupt, Claudia Münger-Beyeler, Leilla Musso, Andreas Nagy, Michaela Neagu, Cristina Nichita, Jan Niess, Natacha Noël, Andreas Nydegger, Nicole Obialo, Carl Oneta, Cassandra Oropesa, Ueli Peter, Daniel Peternac, Laetitia Marie Petit, Franziska Piccoli-Gfeller, Julia Beatrice Pilz, Valérie Pittet, Nadia Raschle, Ronald Rentsch, Sophie Restellini, Jean-Pierre Richterich, Sylvia Rihs, Marc Alain Ritz, Jocelyn Roduit, Daniela Rogler, Gerhard Rogler, Jean-Benoît Rossel, Markus Sagmeister, Gaby Saner, Bernhard Sauter, Mikael Sawatzki, Michela Schäppi, Michael Scharl, Martin Schelling, Susanne Schibli, Hugo Schlauri, Sybille Schmid Uebelhart, Jean-François Schnegg, Alain Schoepfer, Frank Seibold, Mariam Seirafi, Gian-Marco Semadeni, David Semela, Arne Senning, Marc Sidler, Christiane Sokollik, Johannes Spalinger, Holger Spangenberger, Philippe Stadler, Michael Steuerwald, Alex Straumann, Bigna Straumann-Funk, Michael Sulz, Joël Thorens, Sarah Tiedemann, Radu Tutuian, Stephan Vavricka, Francesco Viani, Jürg Vögtlin, Roland Von Känel, Alain Vonlaufen, Dominique Vouillamoz, Rachel Vulliamy, Jürg Wermuth, Helene Werner, Paul Wiesel, Reiner Wiest, Tina Wylie, Jonas Zeitz & Dorothee Zimmermann. (2018) Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. Journal of Crohn's and Colitis 12:7, pages 811-818.
Crossref
Carolijn Smids, Carmen S Horjus Talabur Horje, Julia Drylewicz, Britt Roosenboom, Marcel J M Groenen, Elly van Koolwijk, Ellen G van Lochem & Peter J Wahab. (2018) Intestinal T Cell Profiling in Inflammatory Bowel Disease: Linking T Cell Subsets to Disease Activity and Disease Course. Journal of Crohn's and Colitis 12:4, pages 465-475.
Crossref
Johan Burisch, Ryan Ungaro, Ida Vind, Michelle V Prosberg, Flemming Bendtsen, Jean-Frederic Colombel & Marianne K. Vester-Andersen. (2017) Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 11:10, pages 1200-1204.
Crossref
Ashwin N. Ananthakrishnan, Ramnik J. Xavier & Daniel K. Podolsky. 2017. Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 33 47 .
Joana Torres, Flavio Caprioli, Konstantinos H. Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C. Lee, James O. Lindsay, David T. Rubin, Remo Panaccione & Jean-Frédéric Colombel. (2016) Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 10:12, pages 1385-1394.
Crossref
Gert Huppertz-Hauss, Marte Lie Høivik, Lars-Petter Jelsness-Jørgensen, Magne Henriksen, Ole Høie, Jørgen Jahnsen, Geir Hoff, Bjørn Moum & Tomm Bernklev. (2016) Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis. Inflammatory Bowel Diseases 22:7, pages 1679-1687.
Crossref
Mirthe E. van der Valk, Marie-Josée J. Mangen, Mirjam Severs, Mike van der Have, Gerard Dijkstra, Ad A. van Bodegraven, Herma H. Fidder, Dirk J. de Jong, C. Janneke van der Woude, Mariëlle J. L. Romberg-Camps, Cees H. M. Clemens, Jeroen M. Jansen, Paul C. van de Meeberg, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Clemens Bolwerk, J. Reinoud Vermeijden, Peter D. Siersema, Max Leenders & Bas Oldenburg. (2016) Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up. PLOS ONE 11:4, pages e0142481.
Crossref
Eun Suk Jung, Jae Hee Cheon, Ji Hyun Lee, Soo Jung Park, Hui Won Jang, Sook Hee Chung, Myoung Hee Park, Tai-Gyu Kim, Heung-Bum Oh, Suk-Kyun Yang, Sang Hyoung Park, Jae Yong Han, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Min Goo Lee. (2016) HLA-C*01 is a Risk Factor for Crohnʼs Disease. Inflammatory Bowel Diseases 22:4, pages 796-806.
Crossref
James J. Ashton, Tracy Coelho, Sarah Ennis, Bhumita Vadgama, Akshay Batra, Nadeem A. Afzal & R. Mark Beattie. (2016) Endoscopic Versus Histological Disease Extent at Presentation of Paediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 62:2, pages 246-251.
Crossref
P. C. Lunney, V. C. Kariyawasam, R. R. Wang, K. L. Middleton, T. Huang, C. P. Selinger, J. M. Andrews, P. H. Katelaris & R. W. L. Leong. (2015) Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Alimentary Pharmacology & Therapeutics 42:1, pages 61-70.
Crossref
Ailsa L. Hart & Siew C. Ng. (2015) Crohn's disease. Medicine 43:5, pages 282-290.
Crossref
Jae Hyuk ChoiEun Soo KimKwang Bum ChoKyung Sik ParkYoo Jin LeeSang Min LeeYu Jin KangByung Ik JangKyeong Ok Kim. (2015) Old Age at Diagnosis Is Associated With Favorable Outcomes in Korean Patients With Inflammatory Bowel Disease. Intestinal Research 13:1, pages 60.
Crossref
Hui-Fei Cui. (2015) Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study. Medical Science Monitor 21, pages 163-170.
Crossref
Dana Duricova, Johan Burisch, Tine Jess, Corinne Gower-Rousseau & Peter L. Lakatos. (2014) Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. Journal of Crohn's and Colitis 8:11, pages 1351-1361.
Crossref
Kiyonori Kobayashi, Fumihito Hirai, Makoto Naganuma, Kenji Watanabe, Takafumi Ando, Hiroshi Nakase, Katsuyoshi Matsuoka & Mamoru Watanabe. (2014) A randomized clinical trial of mesalazine suppository: The usefulness and problems of central review of evaluations of colonic mucosal findings. Journal of Crohn's and Colitis 8:11, pages 1444-1453.
Crossref
Gary R. Lichtenstein, Andrew C. Barrett, Enoch Bortey, Craig Paterson & William P. Forbes. (2014) Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative Colitis. Inflammatory Bowel Diseases 20:8, pages 1399-1406.
Crossref
Inger C. Solberg, Milada Cvancarova, Morten H. Vatn & Bjørn Moum. (2014) Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study). Inflammatory Bowel Diseases 20:1, pages 60-68.
Crossref
Daniel Sjöberg, Tommy Holmström, Märit Larsson, Anne-Lie Nielsen, Lars Holmquist, Anders Ekbom & Anders Rönnblom. (2013) Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005–2009 — Results from the IBD Cohort of the Uppsala Region (ICURE). Journal of Crohn's and Colitis 7:9, pages e351-e357.
Crossref
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, Heda Amarante, Pal Miheller, Brian Feagan, Geert D'Haens, Philippe Marteau, Walter Reinisch, Andreas Sturm, Flavio Steinwurz, Laurence Egan, Julián Panés, Edouard Louis, Jean-Frédéric Colombel & Remo Panaccione. (2013) Optimising monitoring in the management of Crohn's disease: A physician's perspective. Journal of Crohn's and Colitis 7:8, pages 653-669.
Crossref
Talat Bessissow, Bart Lemmens, Marc Ferrante, Raf Bisschops, Kristel Van Steen, Karel Geboes, Gert Van Assche, Séverine Vermeire, Paul Rutgeerts & Gert De Hertogh. (2012) Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing. American Journal of Gastroenterology 107:11, pages 1684-1692.
Crossref
Marte L. Hoivik, Bjorn Moum, Inger C. Solberg, Milada Cvancarova, Ole Hoie, Morten H. Vatn & Tomm Bernklev. (2012) Health-Related Quality of Life in Patients with Ulcerative Colitis After a 10-year Disease Course: Results from the IBSEN Study. Inflammatory Bowel Diseases 18:8, pages 1540-1549.
Crossref
Gianmichele Meucci, Renato Fasoli, Simone Saibeni, Daniela Valpiani, Renzo Gullotta, Enrico Colombo, Renata DʼIncà, Maddalena Terpin & Giovanni Lombardi. (2012) Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study. Inflammatory Bowel Diseases 18:6, pages 1006-1010.
Crossref
Bernd Bokemeyer, Daan Hommes, Ivo Gill, Per Broberg & Axel Dignass. (2012) Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. Journal of Crohn's and Colitis 6:4, pages 476-482.
Crossref
Marte Lie Høivik, Tomm Bernklev, Inger Camilla Solberg, Milada Cvancarova, Idar Lygren, Jørgen Jahnsen & Bjørn Moum. (2012) Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study. Journal of Crohn's and Colitis 6:4, pages 441-453.
Crossref
Fernando Magro, Andreia Rodrigues, Ana Isabel Vieira, Francisco Portela, Isabelle Cremers, José Cotter, Luis Correia, Maria Antónia Duarte, Maria Lourdes Tavares, Paula Lago, Paula Ministro, Paula Peixe, Susana Lopes & Elizabeth Benito Garcia. (2012) Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts. Inflammatory Bowel Diseases 18:3, pages 573-583.
Crossref
Sung-Ae Jung. (2012) Differential Diagnosis of Inflammatory Bowel Disease: What Is the Role of Colonoscopy?. Clinical Endoscopy 45:3, pages 254.
Crossref
K. McSharry, A. M. Dalzell, K. Leiper & W. El-Matary. (2011) Systematic review: the role of tacrolimus in the management of Crohn’s disease. Alimentary Pharmacology & Therapeutics 34:11-12, pages 1282-1294.
Crossref
A. Qasim, N. Ullah, P. Crotty, N. Swan, N. Breslin, B. Ryan, W. Torreggiani, E. Eguare, P. Neary, H. O’Connor & C. O’Morain. (2011) A changing trend in the management of patients with newly diagnosed Crohn’s disease. Irish Journal of Medical Science 180:3, pages 643-647.
Crossref
Eun Suk Jung, Seung Won Kim, Chang Mo Moon, Dong-Jik Shin, Nak-Hoon Son, Eun Soo Kim, Hyun Jung Lee, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2011) Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population. Life Sciences 89:9-10, pages 289-294.
Crossref
Ailsa L. Hart & Siew C. Ng. (2011) Crohn’s disease. Medicine 39:4, pages 229-236.
Crossref
Alexander C Ford, Khurram J Khan, Nicholas J Talley & Paul Moayyedi. (2011) 5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis. American Journal of Gastroenterology 106:3, pages 413-420.
Crossref
. (2011) Doença de Crohn intestinal: manejo. Revista da Associação Médica Brasileira 57:1, pages 10-13.
Crossref
. (2011) Intestinal Crohn's disease: management. Revista da Associação Médica Brasileira (English Edition) 57:1, pages 10-13.
Crossref
. (2011) Intestinal Crohn's disease: management. Revista da Associação Médica Brasileira 57:1, pages 10-13.
Crossref
Derek P Jewell, Lloyd R Sutherland, John WD McDonald & Brian G Feagan. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 232 247 .
S. P. Jørgensen, J. Agnholt, H. Glerup, S. Lyhne, G. E. Villadsen, C. L. Hvas, L. E. Bartels, J. Kelsen, L. A. Christensen & J. F. Dahlerup. (2010) Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study. Alimentary Pharmacology & Therapeutics 32:3, pages 377-383.
Crossref
Christina Y. Ha, Rodney D. Newberry, Christian D. Stone & Matthew A. Ciorba. (2010) Patients With Late-Adult-Onset Ulcerative Colitis Have Better Outcomes Than Those With Early Onset Disease. Clinical Gastroenterology and Hepatology 8:8, pages 682-687.e1.
Crossref
A. M. El-Tawil. (2010) Smoking and inflammatory bowel diseases: what in smoking alters the course?. International Journal of Colorectal Disease 25:6, pages 671-680.
Crossref
Francisco Portela, Fernando Magro, Paula Lago, José Cotter, Isabelle Cremers, João de Deus, Ana Vieira, Horácio Lopes, Paulo Caldeira, Luísa Barros, Jorge Reis, Laura Carvalho, Raquel Gonçalves, Mário J. Campos, Paula Ministro, Maria A. Duarte, Jorge Amil, Susana Rodrigues, Luís Azevedo & A. Costa-Pereira. (2010) Ulcerative colitis in a Southern European country: A national perspective. Inflammatory Bowel Diseases 16:5, pages 822-829.
Crossref
Alissa J. Walsh & Graham L. Radford‐Smith. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease 212 227 .
Eun Soo Kim & Won Ho Kim. (2010) Inflammatory Bowel Disease in Korea: Epidemiological, Genomic, Clinical, and Therapeutic Characteristics. Gut and Liver 4:1, pages 1-14.
Crossref
Fumihito Hirai & Toshiyuki Matsui. (2010) Current Status of Treatment for Patients with Crohn's Disease with Reference to the Japanese Guideline. Nippon Daicho Komonbyo Gakkai Zasshi 63:10, pages 855-862.
Crossref
Bruce E. Sands & Corey A. Siegel. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 1941 1973.e9 .
Morten H. Vatn. (2009) Natural history and complications of IBD. Current Gastroenterology Reports 11:6, pages 481-487.
Crossref
Frans van der Heide, Arie Dijkstra, Rinse K. Weersma, Frans A. Albersnagel, Elise M.J. van der Logt, Klaas Nico Faber, Wim J. Sluiter, Jan H. Kleibeuker & Gerard Dijkstra. (2009) Effects of active and passive smoking on disease course of Crohnʼs disease and ulcerative colitis. Inflammatory Bowel Diseases 15:8, pages 1199-1207.
Crossref
Axel U. Dignass, Bernd Bokemeyer, Henning Adamek, Michael Mross, Lars Vinter-Jensen, Norbert Börner, Jouni Silvennoinen, Gie Tan, Marco Oudkerk Pool, Theo Stijnen, Peter Dietel, Tobias Klugmann, Severine Vermeire, Aomesh Bhatt & Henri Veerman. (2009) Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis. Clinical Gastroenterology and Hepatology 7:7, pages 762-769.
Crossref
Jae Jun Park, Jae Hee Cheon, Bo Young Kim, Duk Hwan Kim, Eun Soo Kim, Tae Il Kim, Kyoung Ryul Lee & Won Ho Kim. (2008) Correlation of Serum-Soluble Triggering Receptor Expressed on Myeloid Cells-1 with Clinical Disease Activity in Inflammatory Bowel Disease. Digestive Diseases and Sciences 54:7, pages 1525-1531.
Crossref
Inger Camilla Solberg, Idar Lygren, Milada Cvancarova, Jrgen Jahnsen, Njaal Stray, Jostein Sauar, Stefan Schreiber, Bjrn Moum & Morten H. Vatn. (2009) Predictive Value of Serologic Markers in a Population-based Norwegian Cohort with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 15:3, pages 406-414.
Crossref
M J L Romberg-Camps, P C Dagnelie, A D M Kester, M A M Hesselink-van de Kruijs, M Cilissen, L G J B Engels, C Van Deursen, W H A Hameeteman, F L Wolters, M G V M Russel & R W Stockbrügger. (2009) Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease. The American Journal of Gastroenterology 104:2, pages 371-383.
Crossref
E. V. LoftusJrJr. 2009. Chronic Inflammation of Liver and Gut. Chronic Inflammation of Liver and Gut 38 45 .
Kelly M. Tarrant, Murray L. Barclay, Christopher M. A. Frampton & Richard B. Gearry. (2008) Perianal Disease Predicts Changes in Crohn's Disease Phenotype-Results of a Population-Based Study of Inflammatory Bowel Disease Phenotype. The American Journal of Gastroenterology 103:12, pages 3082-3093.
Crossref
James Allison, Lisa J. Herrinton, Liyan Liu, Jenny Yu & James Lowder. (2008) Natural History of Severe Ulcerative Colitis in a Community-Based Health Plan. Clinical Gastroenterology and Hepatology 6:9, pages 999-1003.
Crossref
Jeremy Adler, Sheela Raju, Allison S. Beveridge, Sijian Wang, Ji Zhu & Ellen M. Zimmermann. (2008) College adjustment in University of Michigan students with Crohnʼs and colitis. Inflammatory Bowel Diseases 14:9, pages 1281-1286.
Crossref
P.K. Rao Dhruva, P.E. Price & J. Torkington. (2008) Current practice in management of Crohn's disease in Wales. The Surgeon 6:1, pages 26-31.
Crossref
Mahmood Zamirian & Amir Aslani. (2008) Response to Dr. Ze-Zhou Song. The American Journal of Gastroenterology 103:1, pages 241-241.
Crossref
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon 1783 1862 .
. 2008. Surgery of the Anus, Rectum & Colon. Surgery of the Anus, Rectum & Colon 1427 1475 .
. 2008. Tabakabhängigkeit. Tabakabhängigkeit 249 369 .
Inger Camilla Solberg, Morten H. Vatn, Ole Høie, Njaal Stray, Jostein Sauar, Jørgen Jahnsen, Bjørn Moum & Idar Lygren. (2007) Clinical Course in Crohn’s Disease: Results of a Norwegian Population-Based Ten-Year Follow-Up Study. Clinical Gastroenterology and Hepatology 5:12, pages 1430-1438.
Crossref
A. ARATARI, C. PAPI, G. LEANDRO, A. VISCIDO, L. CAPURSO & R. CAPRILLI. (2007) Early versus late surgery for ileo-caecal Crohn’s disease. Alimentary Pharmacology & Therapeutics 26:10, pages 1303-1312.
Crossref
G. BIANCHI PORRO, A. CASSINOTTI, E. FERRARA, G. MACONI & S. ARDIZZONE. (2007) Review article: the management of steroid dependency in ulcerative colitis. Alimentary Pharmacology & Therapeutics 26:6, pages 779-794.
Crossref
Ole Höie, Frank Wolters, Lene Riis, Geir Aamodt, Camilla Solberg, Tomm Bernklev, Selwyn Odes, Iannis A. Mouzas, Marina Beltrami, Ebbe Langholz, Reinhold Stockbrügger, Morten Vatn & Bjorn Moum. (2007) Ulcerative Colitis: Patient Characteristics May Predict 10-Yr Disease Recurrence in a European-Wide Population-Based Cohort. The American Journal of Gastroenterology 102:8, pages 1692-1701.
Crossref
Marian C Aldhous, Hazel E Drummond, Niall Anderson, M Reza Baneshi, Linda A Smith, Ian DR Arnott & Jack Satsangi. (2007) Smoking Habit and Load Influence Age at Diagnosis and Disease Extent in Ulcerative Colitis. The American Journal of Gastroenterology 102:3, pages 589-597.
Crossref
Sang Hyoung Park, Young Min Kim, Suk-Kyun Yang, Sai-Hui Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yun Kyung Cho, Chang-Sik Yu, Kwi-Sook Choi, Jun-Won Chung, Benjamin Kim, Kee Don Choi & Jin-Ho Kim. (2007) Clinical features and natural history of ulcerative colitis in Korea. Inflammatory Bowel Diseases 13:3, pages 278-283.
Crossref
V. SUBRAMANIAN, A. BANERJEE, N. BEHARRY, M. J. G. FARTHING & R. C. G. POLLOK. (2007) Determining the proximal extent of ulcerative colitis: white cell scan correlates well with histological assessment. Alimentary Pharmacology & Therapeutics 25:4, pages 441-446.
Crossref
Ole Hoie, Frank L. Wolters, Lene Riis, Tomm Bernklev, Geir Aamodt, Juan Clofent, Epaminondas Tsianos, Marina Beltrami, Selwyn Odes, Pia Munkholm, Morten Vatn, Reinhold W. Stockbrügger & Bjorn Moum. (2007) Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 Years. Gastroenterology 132:2, pages 507-515.
Crossref
Gabriele Moser. 2007. Psychosomatik in der Gastroenterologie und Hepatologie. Psychosomatik in der Gastroenterologie und Hepatologie 115 136 .
J. Cosnes & Ph. Seksik. (2006) Facteurs environnementaux dans la maladie de CrohnEnvironmental factors in Crohn’s disease. Acta Endoscopica 36:5, pages 679-688.
Crossref
Magne Henriksen, Jrgen Jahnsen, Idar Lygren, Jostein Sauar, ystein Kjellevold, Tom Schulz, Morten H. Vatn & Bjrn Moum. (2006) Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (the IBSEN study). Inflammatory Bowel Diseases 12:7, pages 543-550.
Crossref
Mercedes Domínguez Antonaya. (2006) Orientación diagnóstica y terapéutica de la enfermedad inflamatoria intestinal. FMC - Formación Médica Continuada en Atención Primaria 13:7, pages 334-343.
Crossref
Robert Hilsden & Lloyd Sutherland. 2006. Challenges in Inflammatory Bowel Disease. Challenges in Inflammatory Bowel Disease 369 376 .
Tomm Bernklev, J??rgen Jahnsen, Tom Schulz, Jostein Sauar, Idar Lygren, Magne Henriksen, Nj??l Stray, ??ystein Kjellevold, Erling Aadland, Morten Vatn & Bj??rn Moum. (2005) Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis. European Journal of Gastroenterology & Hepatology 17:10, pages 1037-1045.
Crossref
Robert M Penner, Karen L Madsen & Richard N Fedorak. (2005) Postoperative Crohnʼs Disease. Inflammatory Bowel Diseases 11:8, pages 765-777.
Crossref
Jeong-Sik Byeon, Suk-Kyun Yang, Seung-Jae Myung, Seung Il Pyo, Hyun Ju Park, Young Min Kim, Yun Jung Lee, Seong Soo Hong, Kyu-Jong Kim, Gin Hyug Lee, Hwoon-Yong Jung, Weon-Seon Hong, Jin-Ho Kim & Young Il Min. (2005) Clinical Course of Distal Ulcerative Colitis in Relation to Appendiceal Orifice Inflammation Status. Inflammatory Bowel Diseases 11:4, pages 366-371.
Crossref
B. Sicilia, R. Vicente, M.T. Arroyo, F. Arribas & F. Gomollón. (2005) Cirugía de una cohorte incidente de pacientes con enfermedad de Crohn en Aragón: indicaciones, tipo de cirugía y factores de riesgo asociados. Gastroenterología y Hepatología 28:3, pages 105-109.
Crossref
B. Sicilia, R. Vicente, M.T. Arroyo, F. Arribas & F. Gomollón. (2005) La afectación pancolónica inicial en la colitis ulcerosa predice la necesidad de colectomía: estudio poblacional basado en una cohorte incidente de pacientes en Aragón. Gastroenterología y Hepatología 28:2, pages 55-59.
Crossref
David S. Fefferman & Richard J. Farrell. (2005) Endoscopy in inflammatory bowel disease: Indications, surveillance, and use in clinical practice. Clinical Gastroenterology and Hepatology 3:1, pages 11-24.
Crossref
J. Cosnes. 2005. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice 112 122 .
Remo Panaccione & Lloyd R. Sutherland. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 269 290 .
Derek P Jewell & Lloyd R Sutherland. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 197 210 .
Tanja Birrenbach & Ulrich Böcker. (2004) Inflammatory Bowel Disease and Smoking. Inflammatory Bowel Diseases 10:6, pages 848-859.
Crossref
Roberta Pica, Omero Alessandro Paoluzi, Federico Iacopini, Adriana Marcheggiano, Pietro Crispino, Margherita Rivera, Antonino Bella, Adriana Consolazio & Paolo Paoluzi. (2004) Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis. Inflammatory Bowel Diseases 10:6, pages 731-736.
Crossref
F. L. Wolters, M. G. V. M. Russel & R. W. Stockbrügger. (2004) Has disease outcome in Crohn's disease changed during the last four decades?. Alimentary Pharmacology & Therapeutics 20:5, pages 483-496.
Crossref
Kristine Wiencke, Andrew Sverre Louka, Anne Spurkland, Morten Vatn, the IBSEN study group, Erik Schrumpf & Kirsten Muri Boberg. (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. Journal of Hepatology 41:2, pages 209-214.
Crossref
Bruce E Sands, Joanne E Arsenault, Michael J Rosen, Mazen Alsahli, Laurence Bailen, Peter Banks, Steven Bensen, Athos Bousvaros, David Cave, Jeffrey S Cooley, Herbert L Cooper, Susan T Edwards, Richard J Farrell, Michael J Griffin, David W Hay, Alex John, Sheldon Lidofsky, Lori B Olans, Mark A Peppercorn, Richard I Rothstein, Michael A Roy, Michael J Saletta, Samir A Shah, Andrew S Warner, Jacqueline L Wolf, James Vecchio, Harland S Winter & John K Zawacki. (2003) Risk of Early Surgery for Crohn's Disease: Implications for Early Treatment Strategies. American Journal of Gastroenterology 98:12, pages 2712-2718.
Crossref
E. Carty & D. S. Rampton. (2003) Evaluation of new therapies for inflammatory bowel disease. British Journal of Clinical Pharmacology 56:4, pages 351-361.
Crossref
K. Fellermann. 2003. Chronisch entzündliche Darmerkrankungen. Chronisch entzündliche Darmerkrankungen 111 124 .
Remo Panaccione & Lloyd R. Sutherland. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 269 290 .
Fernando Tavarela Veloso, José Tomé Ferreira, Luísa Barros & Susana Almeida. (2001) Clinical Outcome of Crohn's Disease: Analysis According to the Vienna Classification and Clinical Activity. Inflammatory Bowel Diseases 7:4, pages 306-313.
Crossref
Amado Salvador Pena. (2001) What have we learned from the biological therapies in ulcerative colitis?. The American Journal of Gastroenterology 96:6, pages 1681-1684.
Crossref
Stephen B. Hanauer & William Sandborn. (2001) Management of Crohn's disease in adults. The American Journal of Gastroenterology 96:3, pages 635-643.
Crossref
Alain Bitton, Mark A. Peppercorn, Donald A. Antonioli, John L. Niles, Samir Shah, Athos Bousvaros, Bernard Ransil, Gary Wild, Albert Cohen, Michael D. Deb Edwardes & Anthony C. Stevens. (2001) Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120:1, pages 13-20.
Crossref
Bjørn Moum. (2000) Medical treatment: does it influence the natural course of inflammatory bowel disease?. European Journal of Internal Medicine 11:4, pages 197-203.
Crossref
Diether Ludwig, Susanne Wiener, Andreas Brüning, Karsten Schwarting, Günther Jantschek & Eduard F Stange. (1999) Mesenteric Blood Flow Is Related to Disease Activity and Risk of Relapse in Crohn's Disease: A Prospective Follow-Up Study. American Journal of Gastroenterology 94:10, pages 2942-2950.
Crossref
Paul Rutgeerts, Geert D'Haens, Stephan Targan, Eric Vasiliauskas, Stephen B. Hanauer, Daniel H. Present, Lloyd Mayer, Ruud A. Van Hogezand, Tanja Braakman, Kimberly L. DeWoody, Thomas F. Schaible & Sander J.H. Van Deventer. (1999) Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology 117:4, pages 761-769.
Crossref
Bjørn Moum, Anders Ekbom, Morten H Vatn & Kjell Elgjo. (1999) Change in The Extent of Colonoscopic and Histological Involvement in Ulcerative Colitis Over Time. American Journal of Gastroenterology 94:6, pages 1564-1569.
Crossref
Maureen O'Reilly Brown. (1999) INFLAMMATORY BOWEL DISEASE. Primary Care: Clinics in Office Practice 26:1, pages 141-170.
Crossref
John K. Triantafillidis, Anastasios Emmanouilidis, Orestis N. Manousos, Efstathios Pomonis, Chrisa Tsitsa, Petros Cheracakis & Charalambos Barbatzas. (1998) Ulcerative Colitis in Greece: Clinicoepidemiological Data, Course, and Prognostic Factors in 413 Consecutive Patients. Journal of Clinical Gastroenterology 27:3, pages 204-210.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.